PhRMA Honors Vaccines Pioneers with Research & Hope Awards

  PhRMA Honors Vaccines Pioneers with Research & Hope Awards

Business Wire

WASHINGTON -- September 11, 2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) announced
today the recipients of the 2013 Research & Hope Awards, honoring outstanding
achievements in vaccines research and immunization by individuals and research
teams in the biopharmaceutical sector, academic/public research and health
care provider communities.

“Over the last century, vaccines have transformed the public health landscape
in the United States and around the world, preventing disease and improving
the quality of life for multiple generations,” said PhRMA President and CEO
John J. Castellani. “PhRMA is proud to honor the recipients of this year’s
Research & Hope Awards. These inspiring collaborators within the
biopharmaceutical ecosystem have helped drive the latest advances in vaccines
and immunization to the benefit of patients everywhere.”

Vaccines are one of the most profound achievements of biomedical science and
public health, resulting in the eradication of smallpox, near elimination of
polio, rubella and measles, and the prevention of diseases like hepatitis A
and B, pneumonia and some cancers caused by viruses. Innovative vaccines and
immunization practices have protected countless children and families from
needless illness. Building on this illustrious history, advances in scientific
areas such as genomics are enabling researchers to develop not only new
preventative vaccines, but also therapeutic vaccines for many types of cancer,
HIV/AIDS, hepatitis and autoimmune disorders.

“Vaccines have made a profound impact on public health and have played a
pivotal role in improving patient longevity in the U.S. and abroad,” said Bob
Hugin, PhRMA Chairman and Chairman and CEO of Celgene Corp. “The incredible
value that medicines and vaccines provide to society as a whole is truly
astounding and would be impossible without the collaborative nature of the
medical innovation ecosystem. The recipients of the 2013 Research & Hope
Awards should be very proud of their achievements and the remarkable progress
that is yet to come.”

Recipients of the PhRMA 2013 Research & Hope Awards are:

The PhRMA Research & Hope Award for Biopharmaceutical Industry Research in
Vaccine Development

  *GlaxoSmithKline Malaria Vaccine Team

The GlaxoSmithKline Malaria Vaccine Team, led by Dr. Sophie Biernaux, is
receiving the 2013 PhRMA Research & Hope Award for Biopharmaceutical Industry
Research for its ongoing development of a vaccine against malaria targeted to
children in Sub-Saharan Africa. For more information on the team’s work, now
in the final stages of a large, multi-center Phase III clinical trial, see the
video  and team bio.

The PhRMA Research & Hope Award for Academic or Public Research in Vaccine
Development

  *Douglas R. Lowy, MD
    National Cancer Institute
  *John T. Schiller, PhD
    National Cancer Institute

Drs. Lowy and Schiller are receiving the 2013 PhRMA Research & Hope Award for
Academic or Public Research for the discovery of the human papilloma virus
(HPV) vaccine for the prevention of cervical cancer. For more information on
their pivotal work, see the video  and  bios.

The PhRMA Research & Hope Award for Patient and Community Health

  *Linda Yu-Sing Fu, M.D., M.Sc.
    Children’s National Medical Center (CNMC)

Dr. Fu, on behalf of her team at CNMC, is receiving the 2013 PhRMA Research &
Hope Award for Patient and Community Health for their efforts to increase
awareness of the importance of childhood immunization and raise the quality of
immunization delivery to an at-risk population in the District of Columbia.
For more information, see the video and  bio.

Recipients of the Biopharmaceutical Industry Research and Academic or Public
Research Awards were selected by the Science Advisory Board of the PhRMA
Foundation following an open nominations process. The recipient of the Patient
and Community Health Award was chosen by an inter-departmental committee of
representatives from PhRMA.

PhRMA is joined by five health advocacy partners in recognizing the 2013
Research & Hope Awards honorees: the American Cancer Society Cancer Action
Network (ACS CAN), American Nurses Association, American Osteopathic
Association, Malaria No More and National Association of School Nurses. Media
partners for this year’s program are: WUSA-9, BioCentury Publications, “The
Pink Sheet,” Pharmaceutical Executive, pharmaphorum and SCRIP Intelligence.

For more information on the 2013 Research & Hope Awards, including honoree
biographies and videos of the honorees, visit http://www.phrma.org/awards.

For more information on the history and public health impact of vaccines,
download PhRMA’s new 2013 Vaccines Fact Book.

To learn about the nearly 300 vaccines in development for both preventative
and therapeutic uses, see PhRMA’s new Vaccines in Development report.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents
the country’s leading innovative biopharmaceutical research and biotechnology
companies, which are devoted to discovering and developing medicines that
enable patients to live longer, healthier, and more productive lives. Since
2000, PhRMA member companies have invested approximately $550 billion in the
search for new treatments and cures, including an estimated $48.5 billion in
2012 alone.

Find PhRMA Online:

  *Website – http://www.phrma.org
  *Facebook – www.facebook.com/PhRMA
  *Blog – www.phrma.org/catalyst
  *Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress
  *YouTube – www.youtube.com/PhRMApress

For information on how innovative medicines save lives, visit:
http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit:
http://www.pparx.org

For information on ensuring the flow of medicines during public health
emergencies, visit http://www.rxresponse.org

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130911005390/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50706667&lang=en

Contact:

Pharmaceutical Research and Manufacturers of America (PhRMA)
Jennifer Wall, 202-835-3460
 
Press spacebar to pause and continue. Press esc to stop.